论文部分内容阅读
Idiopathic pulmonary fibrosis(IPF)is a progressive life-threatening disease that is characterized anatomically by scarring of the lungs and symptomatically by exertional dyspnea.Currently,there is no efficient therapy strategy; the only one IPF-specific drug is pirfenidone(PFD),which is a multi-target drug.